This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n12http://linked.opendata.cz/resource/drugbank/drug/DB08400/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08400/identifier/pdb/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08400/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08400/identifier/pubchem-substance/

Statements

Subject Item
n2:DB08400
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08400 n7:DB08400
dcterms:title
4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid
adms:identifier
n9:99444871 n10:PIX n11:25243828 n12:DB08400
n3:IUPAC-Name
n4:271B547F-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5485-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5484-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5481-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5482-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5483-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B547D-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B547B-363D-11E5-9242-09173F13E4C5 n4:271B547E-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B547C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B548B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B548C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5486-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5487-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5489-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5488-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B548A-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5491-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5493-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5494-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5490-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B548F-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5492-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5480-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B548D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B548E-363D-11E5-9242-09173F13E4C5